1-Hydroxy anthraquinone | CAS:129-43-1
1-Hydroxy anthraquinone
- 名称:1-羟基蒽醌 | 1-Hydroxy anthraquinone
- CAS号:129-43-1
- 别名:1-Hydroxyanthraquinone; 1-Hydroxy-9,10-anthracenedione
- 分子式:C14H8O3
- 分子量:224.22
- EINESC号:204-946-7
产品描述
物理化学性质
熔点 | 194 ºC |
---|
安全数据
没有数据 | 没有数据 |
---|
SDS
来源 | SDS样本 |
---|---|
没有数据 | 没有数据 |
产品合成路线
更多
名称 | CAS号 |
---|
更多
文章
同行评议文献
Toxicologic evaluation of Dichrostachys glomerata extract: subchronic study in rats and genotoxicity tests.Shil C Kothari et al.Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 69, 120-131 (2014-04-10)
Induced mutation spectra at the upp locus in Salmonella typhimurium: response of the target gene in the FU assay to mechanistically different mutagens.Katerina Vlasakova et al.Mutation research, 578(1-2), 225-237 (2005-09-07)
Specificity of base substitutions induced by the acridine mutagen ICR-191: mispairing by guanine N7 adducts as a mutagenic mechanism.S R Sahasrabudhe et al.Genetics, 129(4), 981-989 (1991-12-01)
UV-irradiated 2-methyl-4'-(methylthio)-2-morpholinopropiophenone-containing injection solution produced frameshift mutations in the Ames mutagenicity assay.Mariko Takai et al.Environmental science and pollution research international, 25(10), 10135-10140 (2018-03-01)
Study of T-cell signaling by somatic cell mutagenesis and complementation cloning.Mary Ellen Cvijic et al.Journal of immunological methods, 278(1-2), 293-304 (2003-09-06)
Isolation and characterization of dominant and recessive IL-3-independent hematopoietic transformants.K F Kiser et al.Oncogene, 25(50), 6595-6603 (2006-05-17)
Transformation of MCF-10A cells by random mutagenesis with frameshift mutagen ICR191: a model for identifying candidate breast-tumor suppressors.Helena Zientek-Targosz et al.Molecular cancer, 7, 51-51 (2008-06-07)
Modulation of the potency of promutagens and direct acting mutagens in bacteria by inhibitors of the multidrug resistance mechanism.S De Flora et al.Mutagenesis, 12(6), 431-435 (1997-12-31)
An investigation of DNA mismatch repair capacity under normal culture conditions and under conditions of supra-physiological challenge in human CD4+T cell clones from donors of different ages.Kathryn Annett et al.Experimental gerontology, 40(12), 976-981 (2005-10-12)
Mutagenesis.Leslie Barbour et al.Methods in molecular biology (Clifton, N.J.), 313, 121-127 (2005-08-25)
Genetic characterization of ompH mutants in the deep-sea bacterium Photobacterium sp. strain SS9.D Bartlett et al.Archives of microbiology, 162(5), 323-328 (1994-01-01)
Isolation and characterization of novel phenotype CHO cell mutants defective in peroxisome assembly, using ICR191 as a potent mutagenic agent.Kamran Ghaedi et al.Cell biochemistry and function, 26(6), 684-691 (2008-06-11)
DNA repair: a double-edged sword.Q Wei et al.Journal of the National Cancer Institute, 92(6), 440-441 (2000-03-16)
Acridine mutagenesis of zebrafish (Danio rerio).Richard Hampson et al.Mutation research, 525(1-2), 1-9 (2003-03-26)
Heritable alterations at the adenine phosphoribosyltransferase (APRT) locus in human lymphoblastoid cell lines.S A Amundson et al.Mutation research, 284(2), 287-295 (1992-12-16)
Effects of the umuDC, mucAB, and samAB operons on the mutational specificity of chemical mutagenesis in Escherichia coli: I. Frameshift mutagenesis.M Watanabe et al.Mutation research, 314(1), 27-37 (1994-01-01)
Frameshift mutations induced by the acridine mustard ICR-191 in embryos and in the adult gill and hepatopancreas of rpsL transgenic zebrafish.Takashi Nakamura et al.Mutation research, 578(1-2), 272-283 (2005-07-12)
A modified Vibrio harveyi mutagenicity assay based on bioluminescence induction.B Podgórska et al.Letters in applied microbiology, 42(6), 578-582 (2006-05-19)
Genotoxicity evaluation of a Phragmitis rhizoma extract using a standard battery of in vitro and in vivo assays.No Soo Kim et al.Journal of ethnopharmacology, 241, 112025-112025 (2019-06-13)
High-frequency mutagenesis of human cells and characterization of a mutant unresponsive to both alpha and gamma interferons.R McKendry et al.Proceedings of the National Academy of Sciences of the United States of America, 88(24), 11455-11459 (1991-12-15)
Genotoxicity of rice bran oil extracted by supercritical CO2 extraction.Jae-Suk Choi et al.Biological & pharmaceutical bulletin, 37(12), 1963-1970 (2014-12-03)
Alleviation of mutagenic effects of polycyclic aromatic agents (quinacrine mustard, ICR-191 and ICR-170) by caffeine and pentoxifylline.Jacek Piosik et al.Mutation research, 530(1-2), 47-57 (2003-10-18)
Cytotoxicity and mutagenicity of frameshift-inducing agent ICR191 in mismatch repair-deficient colon cancer cells.W D Chen et al.Journal of the National Cancer Institute, 92(6), 480-485 (2000-03-16)
An improved bacterial test system for the detection and classification of mutagens and carcinogens.B N Ames et al.Proceedings of the National Academy of Sciences of the United States of America, 70(3), 782-786 (1973-03-01)
Attenuation of acridine mutagen ICR-191--DNA interactions and DNA damage by the mutagen interceptor chlorophyllin.Monika Pietrzak et al.Biophysical chemistry, 135(1-3), 69-75 (2008-04-22)
Effects of the umuDC, mucAB, and samAB operons on the mutational specificity of chemical mutagenesis in Escherichia coli: II. Base substitution mutagenesis.M Watanabe et al.Mutation research, 314(1), 39-49 (1994-01-01)
Extensive loss of heterozygosity accounts for differential mutation rate on chromosome 17q in human lymphoblasts.K L Dobo et al.Mutagenesis, 10(1), 53-58 (1995-01-01)
Mutational spectrum of ICR-191 at the hprt locus in human lymphoblastoid cells.S A Taft et al.Environmental and molecular mutagenesis, 23(2), 96-100 (1994-01-01)
A novel bacterial reversion and forward mutation assay based on green fluorescent protein.N F Cariello et al.Mutation research, 414(1-3), 95-105 (1998-06-19)
Use of mutagens to increase rate of immunoglobulin isotype switching of hybridoma cells.M Paizi et al.Hybridoma, 14(1), 85-90 (1995-02-01)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
名称 | CAS号 |
---|
相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称!
- CAS号
- 请正确填写公司名称!
- 请正确填写联系人!
- 请正确填写联系电话!
- 请正确填写联系邮箱!
- 请描述您的问题!